Blog / Archives
Reflation trade turns cautious: 3% Market Sell-Off
The market had a broadbase sell-off today with weakness in all sectors especially commodity stocks such as energy and materials. The 30% rally since March 9th has come to a screeching halt. A global...
H1N1 Flu Pandemic is here but Moderate in Severity
Drug Stocks rally on Flu News On Thursday June 11,the WHO raised its alert on swine flu (H1N1) to the Phase 6 pandemic level calling further spread of the virus inevitable. The Director- General of...
Ten Year Treasury Auction drives Yield to 3.99%
The reflation trade got a big boost from Treasuries today as the latest auction brought yields of close to 4%, much higher than the pricing of the May 9th delayed auction when yields were about...
Reflation trade picks up after Auction
Auction Goes Well The Treasury sold $35 B of 5 Year Bonds at 2.32% higher than the last auction of 2.19% so analysts felt this was a good sign because it was the second strong auction in a row after...
Perfect Storm of Financial Distress from BIO
BIOblog for GEN BIO Super Session Weathering the Perfect Storm of Financial Distress Rod Raynovich 5/20/09 At the end of this session someone in the audience asked, ”You described the Perfect Storm...
Update on Biomarkers From BIO Conf
BIOblog for GEN Update on Biomarkers Rod Raynovich 5/19/09 In the October 1 issue of GEN I wrote a review of the impact of genomics in diagnostics and the potential of “companion diagnostics” or the...
Reflation trade kicks up
The reflation trade picked up the MO today with big winners among commodity and precious metal stocks. Dollar weakness,10 year treasuries hitting 3.2%, and China's appetite for raw materials and...
Swine Flu fear boost Biotechs
The U.S. Government declared an emergency Sunday and released 25% of Relenza and Tamiflu antiviral treatment courses for use by healthcare providers should cases escalate. Tamiflu was developed by...
Macro Reflation trade: Deflation risk persists
An April 14 story on Bloomberg said that the ECB may have to lower interest rates below 1.25% next month to counter the worse recession in six decades. And the FED continued its quantitative easing...
Q1 Biotechnology Update
The March rally improved the performance of the Life Science sector in Q1 but trailed gains in the technology sector. The S&P Healthcare Index lost 8.5% in Q1 compared to the S&P 500 loss of 11.7%....